Topoisomerase 2A gene amplification in breast cancer. Critical evaluation of different FISH probes. (Q54550048)

31 May 2018

title

Topoisomerase 2A gene amplification in breast cancer. Critical evaluation of different FISH probes. (English)

1 reference

31 May 2018

author

Cathy B Moelans

2

1 reference

31 May 2018

Zsuzsanna Varga

1

object named as

Zsuzsanna Varga

1 reference

31 May 2018

Holger Moch

7

object named as

Holger Moch

1 reference

31 May 2018

author name string

Ursina Zuerrer-Hardi

3

1 reference

31 May 2018

Constanze Ramach

4

1 reference

31 May 2018

Silvia Behnke

5

1 reference

31 May 2018

Glen Kristiansen

6

1 reference

31 May 2018

language of work or name

English

0 references

publication date

15 November 2011

1 reference

31 May 2018

Breast Cancer Research and Treatment

published in

1 reference

31 May 2018

volume

133

1 reference

31 May 2018

issue

3

1 reference

31 May 2018

page(s)

929-935

1 reference

31 May 2018

Molecular subtypes of breast cancer and amplification of topoisomerase II alpha: predictive role in dose intensive adjuvant chemotherapy

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1873-8

Gene copy mapping of the ERBB2/TOP2A region in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1873-8

Simultaneous amplification of HER-2 (ERBB2) and topoisomerase IIalpha (TOP2A) genes--molecular basis for combination chemotherapy in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1873-8

Topoisomerase IIalpha gene (TOP2A) amplification and deletion in cancer--more common than anticipated

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1873-8

Amplification and deletion of topoisomerase IIalpha associate with ErbB-2 amplification and affect sensitivity to topoisomerase II inhibitor doxorubicin in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1873-8

Activation of multiple cancer-associated genes at the ERBB2 amplicon in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1873-8

retrospective analysis of topoisomerase IIa amplifications and deletions as predictive markers in primary breast cancer patients randomly assigned to cyclophosphamide, methotrexate, and fluorouracil or cyclophosphamide, epirubicin, and fluorouracil:

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1873-8

HER2 and TOP2A as predictive markers for anthracycline-containing chemotherapy regimens as adjuvant treatment of breast cancer: a meta-analysis of individual patient data

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1873-8

Molecular profiling of invasive breast cancer by multiplex ligation-dependent probe amplification-based copy number analysis of tumor suppressor and oncogenes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1873-8

Aberrations of ERBB2 and TOP2A genes in breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1873-8

Topoisomerase II alpha and responsiveness of breast cancer to adjuvant chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1873-8

Amplification of HER2 and TOP2A and deletion of TOP2A genes in breast cancer investigated by new FISH probes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1873-8

Topoisomerase II-alpha gene deletion is not frequent as its amplification in breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1873-8

Alteration of topoisomerase II-alpha gene in human breast cancer: association with responsiveness to anthracycline-based chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1873-8

Outcome of patients with early-stage breast cancer treated with doxorubicin-based adjuvant chemotherapy as a function of HER2 and TOP2A status

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1873-8

American Society of Clinical Oncology/College of American Pathologists guideline recommendations for human epidermal growth factor receptor 2 testing in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1873-8

10.1007/S10549-011-1873-8

21 January 2018

Identifiers

DOI

1 reference

31 May 2018

1 reference

31 May 2018